Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
92.98
(
1.77%
)
Bitcoin
73,317.09
(
-0.32%
)
News Focus
News Focus
Post# of 230
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

FACT-MASTER

Send PM Follow Ignore
Followers 30
Posts 4805
Boards Moderated 0
Alias Born 03/20/2011

FACT-MASTER

Re: Solarfuture post# 48

Sunday, 09/25/2022 9:33:36 PM

Sunday, September 25, 2022 9:33:36 PM

Post# of 230
Just doing some review of 1Q/22 report here:

https://ih.advfn.com/stock-market/NASDAQ/immatics-nv-IMTX/stock-news/88273266/immatics-announces-first-quarter-2022-financial-re

Here is what caught my attention:

"The next data read-out for the IMA203 monotherapy cohort is planned for 2H 2022."

Hope the results are better than the IMA202 program which was terminated.

The dive on the chart sort of says results could be poor,however it has dropped on lighterish volume. We are well into 2H of 2022.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IMTX News
More IMTX News